Innoviva’s $392 Million Repurchase of Equity Stake

Willkie Farr & Gallagher LLP represented Innoviva in the transaction, while Kirkland & Ellis advised GlaxoSmithKline. Innoviva, Inc. (NASDAQ: INVA) executed definitive agreement to purchase Glaxo…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now